HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-08-17Clinical Trial Update: Growth Hormone to Increase Immune Function in People With HIV [Phase 2]
A Phase 2 clinical trial evaluating growth hormone to boost immune function in people with HIV has completed.
-
CLINICAL_TRIALS research · 2009-08-11Clinical Trial Update: Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs) [Phase 2]
Phase 2 clinical trial update for ADAPTAVIR evaluating safety and potential to eliminate treatment-resistant HIV in peripheral blood mononuc…
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People [Phase 2]
A Phase 2 study evaluated the safety and tolerability of pegylated interferon alfa-2a in HIV-infected individuals.
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People [Phase 2]
A phase 2 clinical trial evaluating whether thalidomide can stimulate T cells in people with HIV; the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV [Phase 3]
This document reports a Phase 3 clinical trial evaluating nevirapine to prevent mother-to-child transmission of HIV; the study status is com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients [Phase 2]
Phase 2 clinical trial assessing whether alendronate combined with calcium and vitamin D improves bone mineral density in HIV-infected patie…
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Zidovudine Levels in HIV Infected Patients Being Treated for HCV [Phase 1, Phase 2]
This clinical trial update reports on zidovudine concentration levels in HIV-infected patients treated for hepatitis C in Phase 1 and Phase …
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Nutrition, Diabetes and Pulmonary TB/HIV [Phase 3]
A Phase 3 clinical trial investigating nutrition, diabetes, and pulmonary tuberculosis/HIV has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: Exercise, Oxidative Stress and HIV
A completed clinical trial investigated the effects of exercise on oxidative stress in people with HIV; results were posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring [Phase 4]
This clinical trial update describes adjusting antiretroviral therapy dosage using therapeutic drug monitoring in people with HIV (Phase 4).
-
CLINICAL_TRIALS trial_result · 2009-07-22Clinical Trial Update: Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects [Phase 1]
Phase 1 clinical trial update assessing the safety and efficacy of etanercept (Enbrel) in HIV-infected subjects; the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-22Clinical Trial Update: Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients [Phase 4]
Phase 4 clinical trial evaluating the effects of mycophenolate mofetil on surrogate markers of cardiovascular disease in HIV-1 infected pati…
-
CLINICAL_TRIALS research · 2009-07-22Clinical Trial Update: Mycophenolate Mofetil in Antiretroviral Naïve Patients 2 (MAN2 Study) [Phase 4]
A Phase 4 clinical trial update for mycophenolate mofetil in antiretroviral-naïve HIV patients (MAN2 study); the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects [Phase 2, Phase 3]
The document reports safety and tolerability results from a rollover Phase 2/Phase 3 trial of tipranavir boosted with ritonavir in HIV-1–inf…
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Single-Blind, Controlled Safety and Immunogenicity Study of Recombinant MVA Virus to Treat HIV Infection [Phase 1, Phase 2]
A phase 1/2 single-blind, controlled study evaluating the safety and immunogenicity of a recombinant MVA-based HIV vaccine in individuals wi…
-
FDA approval · 2009-07-08FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for Isentress (raltegravir) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients [Phase 2]
Phase 2 trial evaluating low-dose tipranavir/ritonavir pharmacokinetics in treatment-naive HIV patients; results have been posted.
-
CLINICAL_TRIALS trial_result · 2009-06-26Clinical Trial Update: A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study [NA]
Completed randomized pharmacokinetic study evaluating once-daily Atazanavir-Saquinavir-Ritonavir and Saquinavir-Ritonavir regimens, and desc…
-
CLINICAL_TRIALS trial_result · 2009-06-25Clinical Trial Update: A Study on the Safety and Anti-HIV Activity of HE2000 in HIV-Infected Patients on Salvage Therapy [Phase 1]
Phase 1 study evaluating the safety and anti-HIV activity of HE2000 in HIV-infected patients on salvage therapy; study status is completed.
-
FDA approval · 2009-06-19FDA Approved: APTIVUS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for APTIVUS (tipranavir) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2009-06-15FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP. This action approves a regulatory sup…
-
CLINICAL_TRIALS trial_result · 2009-06-03Clinical Trial Update: Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis [Phase 2]
Phase 2 trial evaluating the safety and antifungal activity of recombinant interferon-gamma 1b added to standard therapy in cryptococcal men…
-
CLINICAL_TRIALS trial_result · 2009-05-29Clinical Trial Update: Glutathione and Its Precursors in HIV-Infected Patients [Phase 2]
A Phase 2 clinical trial evaluated glutathione and its precursors in HIV-infected patients; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2009-05-27Clinical Trial Update: Effect of Atazanavir on Endothelial Function in HIV-Infected Patients [Phase 4]
A Phase 4 study evaluated the effect of atazanavir on endothelial function in HIV-infected patients with dyslipidemia; the trial has complet…
-
CLINICAL_TRIALS trial_result · 2009-05-20Clinical Trial Update: Peripheral Body Fat Distribution After Switching Zidovudine and Lamivudine to Truvada [Phase 4]
Phase 4 clinical trial update examining peripheral body fat distribution after switching from zidovudine and lamivudine to Truvada in HIV-1 …